文献速递区域麻醉与超声疼痛医学

丁丙诺啡用于外周神经阻滞的疗效与安全性:随机对照试验的荟萃分析

Efficacy and safety of buprenorphine in peripheral nerve blocks: A meta-analysis of randomised controlled trials.
PubMed 文献 · Eur J Anaesthesiol · 2017-01-01

该系统综述与荟萃分析纳入13项随机对照试验共685例患者,评估外周神经阻滞中局部麻醉药联合丁丙诺啡的疗效与安全性。结果显示,联合丁丙诺啡使镇痛时间延长约8.64小时,但术后恶心呕吐风险显著增加(RR 5.0);神经周围给药比肌内注射镇痛更持久,且两者恶心呕吐风险无差异。

要点

  • 外周神经阻滞中局部麻醉药联合丁丙诺啡可延长术后镇痛约8.64小时。
  • 联合丁丙诺啡显著增加术后恶心呕吐风险(RR 5.0)。
  • 神经周围给药比肌内注射镇痛更持久,但恶心呕吐风险相似。

核心结论

  • 局部麻醉药外周神经阻滞中加入丁丙诺啡可延长术后镇痛约8小时,但显著增加术后恶心呕吐风险。
  • 神经周围给药比全身给药更有效,但术后恶心呕吐风险相似。

研究设计与样本

  • 系统综述与随机对照试验的荟萃分析,检索MEDLINE、CENTRAL和EMBASE(截至2016年3月)。
  • 纳入13项随机对照试验,共685例患者。

主要发现

  • 与单用局部麻醉药相比,联合丁丙诺啡的镇痛时间平均差异为8.64小时(95%CI 6.44至10.85;P<0.01)。
  • 丁丙诺啡组术后恶心呕吐的相对风险显著增高(RR 5.0,95%CI 1.12至22.27;P=0.03)。
  • 神经周围给予丁丙诺啡比肌内注射的镇痛时间平均差异为6.87小时(95%CI 4.02至9.71;P<0.01)。
  • 神经周围给药与肌内注射的术后恶心呕吐发生率无显著差异(RR 0.76,95%CI 0.28至2.03;P=0.58)。

临床怎么用

  • 外周神经阻滞时可考虑联合丁丙诺啡以延长镇痛时间,但需警惕术后恶心呕吐风险。
  • 若选择丁丙诺啡,神经周围给药可能优于全身给药,但术后恶心呕吐风险相似。

局限性

  • 结果受异质性影响,未来需要进一步试验,尤其是头对头比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The duration of analgesia provided by nerve blocks is limited if local anaesthetics are administered alone. Therefore, a variety of additives to local anaesthetics have been investigated to prolong postoperative analgesia following single-shot nerve blocks. OBJECTIVE(S): The aims of the current meta-analysis were to assess the efficacy and safety of the addition of perineural buprenorphine to local anaesthetic compared with local anaesthetic alone, or combined with systemic administration of buprenorphine, or other perineural opioids for peripheral nerve blocks. DESIGN: Systematic review and meta-analysis of randomised controlled trials (RCTs). DATA SOURCES: The following data sources were systematically searched: MEDLINE, CENTRAL and EMBASE (till 03/2016). ELIGIBILITY CRITERIA: All RCTs focusing on the efficacy and safety of perineural buprenorphine combined with local anaesthetic compared with local anaesthetic alone, or in combination with systemic buprenorphine, or other perineural opioids for peripheral nerve blocks were included. RESULTS: We included 13 RCTs (685 patients). Participants treated with perineural buprenorphine combined with local anaesthetic showed a longer duration of analgesia compared with those receiving local anaesthetic alone [mean difference 8.64 h, 95% confidence interval (CI) (6.44 to 10.85); P < 0.01]. However, the buprenorphine group had a significantly higher relative risk (RR) for postoperative nausea and vomiting (PONV) [RR 5.0, 95% CI (1.12 to 22.27); P = 0.03]. The perineural administration of buprenorphine provided a longer duration of analgesia than an intramuscular application [mean difference 6.87 h, 95% CI (4.02 to 9.71); P < 0.01] without evidence of a difference in the incidence of PONV between the modes of administration [RR 0.76, 95% CI (0.28 to 2.03); P = 0.58]. CONCLUSION: This meta-analysis revealed that the addition of buprenorphine to a local anaesthetic peripheral nerve block prolongs postoperative analgesia for about 8 h but significantly increases the risk for PONV. Perineural administration is more effective than systemic application but is associated with a similar risk of PONV. However, these results were influenced by heterogeneity so that further trials (especially head-to-head comparisons) are needed in the future. TRIAL REGISTRATION: PROSPERO(www.crd.york.ac.uk) identifier: CRD42016036054.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Schnabel A, Reichl SU, Zahn PK, et al. Efficacy and safety of buprenorphine in peripheral nerve blocks: A meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2017. PMID: 28763315. doi:10.1097/EJA.0000000000000628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。